Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited19.2199490808.9895
Domestic EquitiesMax Healthcare Institute Limited8.6067346194.0255
Domestic EquitiesCipla Limited8.5761261954.0112
Domestic EquitiesDivi's Laboratories Limited8.191059153.8311
Domestic EquitiesDr. Reddys Laboratories Limited7.6362283733.5716
Domestic EquitiesApollo Hospitals Enterprise Limited7.379247053.4514
Domestic EquitiesLupin Limited5.0158112672.3460
Domestic EquitiesFortis Healthcare Limited4.7691242692.2306
Domestic EquitiesLaurus Labs Limited3.9898180941.8661
Domestic EquitiesTorrent Pharmaceuticals Limited3.874848711.8123
Domestic EquitiesAurobindo Pharma Limited3.4159130241.5977
Domestic EquitiesAlkem Laboratories Limited3.187026221.4906
Domestic EquitiesGlenmark Pharmaceuticals Limited2.918270131.3649
Domestic EquitiesMankind Pharma Ltd2.534052651.1852
Domestic EquitiesBiocon Limited2.3824279731.1143
Domestic EquitiesZydus Lifesciences Limited2.3441116331.0964
Domestic EquitiesIPCA Laboratories Limited2.011064730.9406
Domestic EquitiesAbbott India Limited1.56252430.7308
Domestic EquitiesSyngene International Limited1.224288330.5726
Domestic EquitiesPiramal Pharma Ltd1.1520287810.5388
Total 99.9900 46.7672
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited0.0428 0.0200
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.0327 -0.0153
Total 0.0100 0.0047
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.